RETRACTION: Sun exposure related methylation in malignant and non-malignant skin lesions (Retraction of Vol 245, Pg 112, 2007)

被引：0
作者：
Sathyanarayana, Ubaradka G. [1 ,2 ]
Moore, Angela Yen [4 ,5 ,6 ]
Li, Lin [7 ]
Padar, Asha [1 ]
Majmudar, Kuntal [1 ]
Stastny, Victor [1 ]
Makarla, Prakash [2 ]
Suzuki, Makoto [1 ]
Minna, John D. [1 ,3 ]
Feng, Ziding [7 ]
Gazdar, Adi F. [1 ,2 ]
机构：
[1] Univ Texas Southwestern Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, 6000 Harry Hines Blvd, Dallas, TX 75390 USA
[2] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA
[3] Univ Texas Southwestern Med Ctr Dallas, Internal Med, Dallas, TX 75390 USA
[4] Baylor Univ, Med Ctr Dallas, Dept Dermatol, Dallas, TX 75246 USA
[5] Arlington Ctr Dermatol, Arlington, TX 76011 USA
[6] Univ Texas Branch, Dept Dermatol, Galveston, TX 77550 USA
[7] Fred Hutchinson Canc Res Ctr, Publ Hlth Sci Div Seattle, Seattle, WA 98109 USA
来源：
CANCER LETTERS | 2018年 / 432卷
关键词：
D O I：
10.1016/j.canlet.2018.07.010
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：272 / 272
页数：1
相关论文
共 50 条
[41]   Review article: the management of non-cirrhotic non-malignant portal vein thrombosis and concurrent portal hypertension in adults (vol 26, pg 203, 2007) [J].
Spaander, V. M. ;
van Buuren, H. R. ;
Janssen, H. L. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 27 (06) :528-529
[42]   Serum Levels of Soluble Mesothelin-Related Peptides in Malignant and Non-Malignant Asbestos-Related Pleural Disease: Relation with past Asbestos Exposure. [J].
Rojano-Broz, B. ;
Rodriguez-Portal, J. A. ;
Rodriguez-Becerra, E. ;
Rodriguez, D. ;
Alfageme, I. ;
Quero Martinez, A. ;
Diego, C. ;
Leon-Jimenez, A. ;
Isidro Montes, I. ;
Cebollero, P. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
[43]   Identification of UDP-glucuronosyltransferase 1A10 in non-malignant and malignant human breast tissues (vol 73, pg 611, 2008) [J].
Starlard-Davenport, Athena ;
Lyn-Cook, Beverly ;
Radominska-Pandya, Anna .
STEROIDS, 2009, 74 (06) :548-549
[44]   RETRACTION: Diagnostic Performance of Diffusion Kurtosis Imaging for Benign and Malignant Breast Lesions: A Systematic Review and Meta-Analysis (Retraction of Vol 2022, art no 2042736, 2022) [J].
Gu, H. ;
Cui, W. ;
Luo, S. ;
Deng, X. .
APPLIED BIONICS AND BIOMECHANICS, 2023, 2023
[45]   RETRACTION: Endovascular Stent Deployment in the Management of Lesions Related to Internal Carotid Artery Redundancy (Retraction of Vol 116, Pg E903, 2018) [J].
Li, Cong-Hui ;
Gao, Bu-Lang ;
Wang, Ji-Wei ;
Liu, Jian-Feng ;
Li, Hui ;
Yang, Song-Tao ;
Ren, Chun-Feng .
WORLD NEUROSURGERY, 2021, 155 :229-229
[46]   RETRACTION: Straticyte demonstrates prognostic value over oral epithelial dysplasia grade for oral potentially malignant lesion assessment (vol 72, pg 1, 2017) (Retraction of Vol 72, Pg 1, 2017) [J].
Hwang, Jason T. K. ;
Gu, Ying R. ;
Dickson, Benjamin J. ;
Shen, Mi ;
Ralhan, Ranju ;
Walfish, Paul G. ;
Mock, David ;
Pritzker, Kenneth P. H. .
ORAL ONCOLOGY, 2018, 77 :138-138
[47]   RETRACTION: Silence of MACC1 decreases cell migration and invasion in human malignant melanoma through inhibiting the EMT (Retraction of Vol 10, Pg 258, 2016) [J].
Ding, Yingguo ;
Li, Xiaomin ;
Hong, Dongsheng ;
Jiang, Li ;
He, Yong ;
Fang, Hong .
BIOSCIENCE TRENDS, 2021, 15 (05) :E1-E1
[48]   RETRACTION: MicroRNA-145 inhibits the malignant phenotypes of gastric carcinoma cells via downregulation of fascin 1 expression (Retraction of Vol 13, Pg 1033, 2016) [J].
Xue, Minghui ;
Zhao, Lunde ;
Yang, Fang ;
Li, Zhenjuan ;
Li, Guangyan .
MOLECULAR MEDICINE REPORTS, 2022, 25 (03)
[49]   RETRACTION: LINC-PINT Inhibited Malignant Progression of Bladder Cancer by Targeting miR-155-5p (Retraction of Vol 13, Pg 4393, 2021) [J].
Han, X. ;
Liu, J. ;
Liu, Y. ;
Mou, L. ;
Li, C. .
CANCER MANAGEMENT AND RESEARCH, 2023, 15 :1267-1267
[50]   RETRACTION: Small interfering RNA-induced silencing of galectin-3 inhibits the malignant phenotypes of osteosarcoma in vitro (Retraction of Vol 12, Pg 6316, 2015) [J].
Lei, Pengfei ;
He, Hongbo ;
Hu, Yihe ;
Liao, Zhan .
MOLECULAR MEDICINE REPORTS, 2021, 24 (03)
12345